PRAXIS PRECISION MEDICINES, INC. Payments of Stock Issuance Costs
PRAXIS PRECISION MEDICINES, INC. (PRAX) reported Payments of Stock Issuance Costs of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-05.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2024-03-05
- PRAXIS PRECISION MEDICINES, INC. payments of stock issuance costs for the quarter ending 2023-06-30 was $4.48M.
- PRAXIS PRECISION MEDICINES, INC. payments of stock issuance costs for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- PRAXIS PRECISION MEDICINES, INC. payments of stock issuance costs for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- PRAXIS PRECISION MEDICINES, INC. payments of stock issuance costs for the quarter ending 2022-09-30 was $109.00K.
- PRAXIS PRECISION MEDICINES, INC. payments of stock issuance costs for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- PRAXIS PRECISION MEDICINES, INC. payments of stock issuance costs for fiscal 2022 was $262.00K, a 54.43% decline from fiscal 2021.
- PRAXIS PRECISION MEDICINES, INC. payments of stock issuance costs for fiscal 2021 was $575.00K.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-05 | |||
| 2023-06-30 | $4.48M 10-Q · filed 2023-11-07 | $4.48M derived: sum of 2 quarters · filed 2023-11-07 | $4.48M derived: sum of 3 quarters · filed 2024-03-05 | $4.59M derived: sum of 4 quarters · filed 2024-03-05 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-11 | $0.00 derived: sum of 2 quarters · filed 2024-03-05 | $109.00K derived: sum of 3 quarters · filed 2024-03-05 | $109.00K derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $109.00K derived: sum of 2 quarters · filed 2024-03-05 | $109.00K derived: sum of 3 quarters · filed 2024-03-05 | $262.00K 10-K · filed 2024-03-05 |
| 2022-09-30 | $109.00K 10-Q · filed 2023-11-07 | $109.00K derived: sum of 2 quarters · filed 2023-11-07 | $262.00K 10-Q · filed 2022-11-09 | $969.00K derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $262.00K 10-Q · filed 2022-08-08 | $860.00K derived: sum of 3 quarters · filed 2023-05-11 | $860.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2022-03-31 | $262.00K 10-Q · filed 2023-05-11 | $860.00K derived: sum of 2 quarters · filed 2023-05-11 | $860.00K derived: sum of 3 quarters · filed 2023-05-11 | $1.09M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $598.00K 10-K · filed 2022-02-28 | $598.00K derived: sum of 2 quarters · filed 2022-11-09 | $827.00K derived: sum of 3 quarters · filed 2023-02-07 | $575.00K 10-K · filed 2023-02-07 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $229.00K derived: sum of 2 quarters · filed 2023-02-07 | $575.00K 10-Q · filed 2022-11-09 | $3.67M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-06-30 | $229.00K 10-K · filed 2023-02-07 | $575.00K 10-Q · filed 2022-08-08 | $3.67M derived: sum of 3 quarters · filed 2023-02-07 | $3.82M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-03-31 | $575.00K 10-Q · filed 2022-05-09 | $3.44M derived: sum of 2 quarters · filed 2022-05-09 | $3.59M derived: sum of 3 quarters · filed 2022-05-09 | $3.60M derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $2.86M 10-K · filed 2022-02-28 | $3.02M derived: sum of 2 quarters · filed 2022-02-28 | $3.02M derived: sum of 3 quarters · filed 2022-02-28 | $3.02M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-09-30 | $154.00K 10-K · filed 2022-02-28 | $158.00K derived: sum of 2 quarters · filed 2022-02-28 | $1.12M 10-Q · filed 2021-11-03 | |
| 2020-06-30 | $4.00K 10-K · filed 2022-02-28 | $13.00K 10-Q · filed 2021-08-16 | ||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |